Examkin

Soru

Zorluk: Çok zorDiagnostic Workup and Test Sequencing

A 42-year-old woman is evaluated in the clinic for a 1-year history of progressive weight gain, new-onset facial hair growth, and easy bruising. Her blood pressure is 155/95 mmHg, and her BMI is 34 kg/m^2. Physical examination reveals facial plethora, supraclavicular fat pads, and broad violaceous striae across her abdomen. Proximal muscle weakness is noted on neurologic examination. Initial laboratory evaluation shows a 24-hour urine free cortisol level that is 4 times the upper limit of normal. A low-dose (1 mg) overnight dexamethasone suppression test demonstrates a morning serum cortisol of 14 µg/dL (normal: < 1.8 µg/dL). Subsequent testing reveals a plasma adrenocorticotropic hormone (ACTH) level of 85 pg/mL (normal: 10-60 pg/mL). An MRI of the pituitary gland is performed and demonstrates a 4-mm hypoenhancing lesion in the right anterior pituitary gland. Which of the following is the most appropriate next step in the diagnostic workup?

  1. Inferior petrosal sinus samplingCevap
  2. B
    Transsphenoidal surgical resection
  3. C
    High-dose (8 mg) dexamethasone suppression test
  4. D
    Computed tomography of the chest and abdomen
  5. E
    Peripheral corticotropin-releasing hormone stimulation test

Cevap

Inferior petrosal sinus sampling
The correct answer is inferior petrosal sinus sampling (IPSS). The patient has confirmed hypercortisolism that is ACTH-dependent (ACTH > 20 pg/mL). The next step in evaluating ACTH-dependent Cushing's syndrome is a pituitary MRI. However, distinguishing a true ACTH-secreting pituitary adenoma (Cushing disease) from an incidentaloma and a concurrent ectopic ACTH-secreting tumor can be challenging. Because non-functioning pituitary incidentalomas are found in approximately 10% of the general population, guidelines mandate that only pituitary lesions measuring 6 mm or larger on MRI are definitively diagnostic of Cushing disease. For patients with a normal MRI or a lesion less than 6 mm, IPSS is the gold standard diagnostic step. IPSS measures the central-to-peripheral ACTH gradient (with and without corticotropin-releasing hormone stimulation) to definitively confirm a pituitary source prior to neurosurgery.

Adım Adım Çözüm

1
Analyze the initial screening and confirmatory labs.
Elevated 24-hour urine free cortisol and failure to suppress on low-dose dexamethasone confirm the diagnosis of hypercortisolism (Cushing's syndrome).
Establishing the presence of Cushing's syndrome is the required first step before localizing the source.
2
Evaluate the plasma ACTH level.
The ACTH level is 85 pg/mL (elevated).
An unsuppressed ACTH level (typically > 20 pg/mL) indicates ACTH-dependent Cushing's syndrome, which requires differentiating a pituitary source (Cushing disease) from an ectopic source.
3
Interpret the pituitary MRI findings in the context of the biochemical evaluation.
The MRI shows a 4-mm lesion. Because pituitary incidentalomas are present in up to 10% of the general population, a lesion smaller than 6 mm cannot be definitively established as the ACTH source without further biochemical testing.
Relying on a microadenoma < 6 mm risks a false-positive localization, which could lead to unnecessary transsphenoidal surgery.
4
Determine the definitive test to confirm a central vs. peripheral ACTH source.
Inferior petrosal sinus sampling (IPSS) with CRH stimulation must be ordered.
IPSS directly measures the ACTH gradient between the pituitary venous drainage and peripheral blood, serving as the gold standard to confirm Cushing disease before surgical intervention.

Anahtar Kavram

In patients with ACTH-dependent Cushing's syndrome and a pituitary MRI demonstrating a normal gland or a microadenoma less than 6 mm, inferior petrosal sinus sampling (IPSS) is required to differentiate pituitary-dependent Cushing disease from ectopic ACTH syndrome.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru